82: GLP-1s Beyond Weight Loss – The Future of Women’s Health, Fertility, Hormones, and Longevity | SXSW Panel Discussion Featuring McCall McPherson, Natalie Crawford, Jessica Shepherd & Shannon Ritchey

What if GLP-1 medications are not just changing weight loss—but completely transforming the future of women’s health?In this special SXSW panel discussion, Shannon Ritchey moderates an eye-opening conversation with leading experts McCall McPherson, Natalie Crawford, and Jessica Shepherd about the rapidly evolving role of GLP-1 medications in fertility, thyroid health, inflammation, menopause, longevity, metabolic health, and chronic disease prevention.This conversation goes far beyond weight loss. The panel explores how GLP-1 medications may reduce systemic inflammation, improve insulin resistance, support fertility outcomes, influence hormone health during perimenopause and menopause, protect cardiovascular health, and potentially reshape the future of longevity medicine.The discussion also tackles common myths, cancer fears, muscle loss concerns, microdosing strategies, fertility safety, lifestyle foundations, and the importance of preserving muscle while using these medications.🔑 Key Topics CoveredWhy GLP-1 medications are far more than “weight loss drugs”How GLP-1s improve insulin sensitivity and metabolic functionThe powerful role GLP-1s may play in reducing systemic inflammationWhy microdosing GLP-1s is becoming an emerging strategy in medicineThe truth about thyroid cancer concerns and current research findingsHow under-fueling and poor nutrition contribute to muscle loss on GLP-1sWhy strength training and protein intake are essential while using GLP-1sThe connection between inflammation, thyroid disease, and metabolic dysfunctionHow GLP-1s may support fertility in women with PCOS and insulin resistanceWhy GLP-1s should be stopped before pregnancy attemptsThe impact of chronic inflammation on ovarian reserve and fertility outcomesHow GLP-1s may improve endometriosis symptoms and inflammatory reproductive conditionsThe role of GLP-1s in perimenopause, menopause, and hormonal agingWhy estrogen decline impacts glucose regulation and inflammationThe connection between visceral fat, inflammation, and chronic diseaseEmerging research on GLP-1s, addiction behavior, fatty liver disease, and longevityWhy personalized medicine and lifestyle intervention remain essential🧠 GLP-1s Are Not Just About Eating LessOne of the strongest themes throughout the panel:👉 GLP-1 medications are not simply making people lose weight because they eat less.According to McCall McPherson, these medications fundamentally improve:Metabolic functionInsulin sensitivityInflammatory pathwaysPhysiological responses to foodThis is especially important for women with:Thyroid dysfunctionPCOSAutoimmune diseaseMenopause-related metabolic changesThe panel repeatedly emphasizes:👉 Weight gain is often not a willpower problem—it is a metabolic and inflammatory problem. ⚡ The Emerging Power of MicrodosingA major topic discussed is microdosing GLP-1s.What Is Microdosing?Using:Much smaller dosesMore personalized dosing strategiesFlexible adjustments based on symptoms and goalsRather than aggressively increasing medication doses, microdosing may help:Reduce nauseaImprove tolerabilityAllow proper fueling and protein intakePreserve muscle massMaintain metabolic benefitsMcCall McPherson explains that many patients experience:Significant inflammation reductionMetabolic improvementBetter energy…even at very low doses.🔥 Inflammation: The Hidden Driver of DiseaseThroughout the panel, inflammation is described as one of the biggest underlying drivers of:Fertility strugglesThyroid diseaseInsulin resistanceCardiovascular diseaseJoint painMenopausal symptomsThe panelists repeatedly explain that GLP-1s appear to dramatically reduce inflammation—sometimes within days.Why This MattersReducing inflammation may influence:Hormonal signalingOvarian functionMetabolic flexibilityLongevity outcomesThis is one reason the panel believes GLP-1s may eventually become indicated for many conditions beyond obesity and diabetes.🦋 Thyroid Disease, Autoimmunity & GLP-1sMcCall McPherson shares extensive clinical observations from treating thyroid patients with GLP-1s.Key Insights DiscussedSignifica